OCA

FDA staff unsure NASH drug’s ‘modest’ benefits outweigh safety risks
BioPharma Dive
Wed, 05/17/23 - 10:57 pm
FDA
NASH
OCA
obeticholic acid
Intercept Pharma
FDA accepts Intercept’s resubmitted NDA for obeticholic acid
Clinical Trials Arena
Thu, 01/26/23 - 10:51 am
FDA
Intercept Pharma
OCA
obeticholic acid
NASH
By summer solstice, we'll know the fate of Intercept's NASH drug
Endpoints
Thu, 01/19/23 - 09:39 am
Intercept Pharmaceuticals
FDA
NASH
obeticholic acid
OCA
Two years after CRL, Intercept will meet with FDA later this month to discuss new analysis of NASH drug
Endpoints
Thu, 07/7/22 - 10:28 am
Intercept Pharma
OCA
obeticholic acid
FDA
NASH
Intercept Tries to Outrun Pharma in Race for the Next Blockbuster
Bloomberg
Thu, 04/11/19 - 07:27 pm
liver disease
NASH
Intercept Pharmaceuticals
OCA
obeticholic acid
Intercept Pharma is One Step Closer to Filing for Approval of First NASH Treatment
BioSpace
Tue, 02/19/19 - 10:24 am
NASH
Intercept Pharmaceuticals
obeticholic acid
OCA
clinical trials
Intercept Presents Data form Ph III Substudy That Supports Obeticholic Acid’s Ability to Reverse or Stabilize Fibrosis and Cirrhosis in Primary Biliary Cholangitis (PBC) Patients
CP Wire
Fri, 04/13/18 - 01:10 pm
INTERCEPT
primary biliary cholangitis
obeticholic acid
OCA
Intercept cuts targets for pivotal NASH study
BioPharma Dive
Tue, 02/14/17 - 09:37 am
Intercept Pharma
NASH
clinical trials
OCA
obeticholic acid
FDA advisory panel supports quick approval for Intercept's drug OCA for liver disease
Fierce Biotech
Thu, 04/7/16 - 09:40 pm
FDA
advisory panels
Intercept Pharma
OCA
primary biliary cirrhosis
3 Upcoming FDA Decisions We're Most Excited About
Motley Fool
Sat, 02/13/16 - 09:25 am
FDA
Acadia
Intercept Pharma
Clovis Oncology
Nuplazid
OCA
rociletinib
Intercept's much-hyped NASH drug misses the mark in Phase II
Fierce Biotech
Wed, 10/28/15 - 09:23 am
Intercept Pharmaceuticals
NASH
Sumitomo Dainippon
Japan
OCA
Will This Drug Beat Gilead to Market in NASH?
Investopedia
Sat, 05/23/15 - 11:35 am
Gilead Sciences
NASH
OCA
Intercept Pharma
3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week
24/7 Wall St
Mon, 03/16/15 - 09:16 am
Amgen
evolocumab
Biogen Idec
BIIB037
OCA
obeticholic acid
Intercept Pharmaceuticals
Intercept Liver Drug Needs Safety Review, Researchers Say
Bloomberg
Thu, 11/6/14 - 07:30 pm
Intercept Pharma
OCA
Two drug makers diverge in Wall Street woods, and see huge moves
Marketwatch
Tue, 08/12/14 - 11:44 am
Intercept Pharma
OCA
Dendreon
Intercept Pharma Shares Higher on Positive Fatty Liver Drug Data
TheStreet.com
Mon, 08/11/14 - 06:11 pm
Intercept Pharma
OCA
nonalcoholic steatohepatitis
Today's Top Biotech Stocks to Watch: Intercept Pharmaceuticals and VIVUS
Motley Fool
Thu, 05/29/14 - 09:17 am
Vivus
Intercept Pharmaceuticals
M&A
Aspen Investments
OCA
Intercept Pharma, Government Scientists Spar Over Negative Safety of Liver Drug, Emails Show
TheStreet.com
Tue, 05/20/14 - 09:10 am
Intercept Pharma
liver disease
OCA
obeticholic acid
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Wed, 04/23/14 - 11:57 am
Juxtapid
Otezla
Aegerion
Celgene
GW Pharma
Sativex
Intercept Pharma
OCA
Ironwood Pharmaceuticals
Linzess
Lpath
iSONEP
MannKind
Afrezza
Xtandi
H.P. Acthar Gel
Questcor Pharmaceuticals
eteplirsen
Sarepta Therapeutics
Intercept Pharma rises as analyst raises her price and sales estimates for its liver drug OCA
Yahoo/AP
Mon, 02/10/14 - 05:29 pm
OCA
liver disease
Intercept Pharma

Pages